The purpose of the Act is to improve access to drugs for developing countries that lack the resources to manufacture the drugs and cannot afford to buy them at the usual market cost.
The goal of the Act is to boost medication accessibility for underdeveloped regions that lack the infrastructure to manufacture drugs and cannot afford them at prevailing market rates.